Supply of Sulfadiazine Silver Cream (Pharmaceutical Manufacturing)

The contract pertains to the manufacture and supply of Sulfadiazine Silver Cream, a topical antimicrobial agent specifically indicated for the treatment of burn wounds, under stringent federal medical and defense compliance standards. The product must meet all quality, purity, and efficacy requirements mandated for use by military and federal healthcare systems, ensuring it is suitable for deployment in both clinical and field conditions. The supplier is expected to adhere to current Good Manufacturing Practices and maintain full traceability throughout production to satisfy regulatory and logistical demands of the Department of Defense. The solicitation is structured as a subcontract under the NAICS code 325412, which classifies pharmaceutical preparation manufacturing, and was posted on August 2, 2026, with responses due by August 10, 2026. The contract is administered by the Medical Supply Chain Pharm FSA under the Department of Defense, with performance expected to support national defense medical readiness initiatives. While specific quantities, delivery schedules, or pricing terms are not listed, the procurement is conducted through the DLA DIBBS platform, indicating a formal federal acquisition process requiring full compliance with defense supply chain protocols.